These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9230277)
1. Effects of administration of the chemoprotective agent oltipraz on CYP1A and CYP2B in rat liver and rat hepatocytes in culture. Langouët S; Mahéo K; Berthou F; Morel F; Lagadic-Gossman D; Glaise D; Coles B; Ketterer B; Guillouzo A Carcinogenesis; 1997 Jul; 18(7):1343-9. PubMed ID: 9230277 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Langouët S; Coles B; Morel F; Becquemont L; Beaune P; Guengerich FP; Ketterer B; Guillouzo A Cancer Res; 1995 Dec; 55(23):5574-9. PubMed ID: 7585637 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of oltipraz on CYP1A and CYP2B in rat lung. Le Ferrec E; Ilyin G; Mahéo K; Bardiau C; Courtois A; Guillouzo A; Morel F Carcinogenesis; 2001 Jan; 22(1):49-55. PubMed ID: 11159740 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz. Scholl P; Musser SM; Kensler TW; Groopman JD Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461 [TBL] [Abstract][Full Text] [Related]
5. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes. Takahashi N; Harttig U; Williams DE; Bailey GS Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141 [TBL] [Abstract][Full Text] [Related]
7. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention. Buetler TM; Bammler TK; Hayes JD; Eaton DL Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]
9. Induction of hepatic CYP1A by indole-3-carbinol in protection against aflatoxin B1 hepatocarcinogenesis in rainbow trout. Takahashi N; Stresser DM; Williams DE; Bailey GS Food Chem Toxicol; 1995 Oct; 33(10):841-50. PubMed ID: 7590528 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Langouët S; Furge LL; Kerriguy N; Nakamura K; Guillouzo A; Guengerich FP Chem Res Toxicol; 2000 Apr; 13(4):245-52. PubMed ID: 10775323 [TBL] [Abstract][Full Text] [Related]
11. Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes. Antras-Ferry J; Mahéo K; Chevanne M; Dubos MP; Morel F; Guillouzo A; Cillard P; Cillard J Carcinogenesis; 1997 Nov; 18(11):2113-7. PubMed ID: 9395210 [TBL] [Abstract][Full Text] [Related]
12. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553 [TBL] [Abstract][Full Text] [Related]
13. A comparison of the effect of inducers on the expression of glutathione-S-transferases in the liver of the intact rat and in hepatocytes in primary culture. Langouët S; Morel F; Meyer DJ; Fardel O; Corcos L; Ketterer B; Guillouzo A Hepatology; 1996 Apr; 23(4):881-7. PubMed ID: 8666345 [TBL] [Abstract][Full Text] [Related]
14. 2-(allylthio)pyrazine inhibition of aflatoxin B1-induced hepatotoxicity in rats: inhibition of cytochrome P450 2B- and 3A2-mediated bioactivation. Ha TG; Kim ND Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):69-78. PubMed ID: 9920347 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Manson MM; Ball HW; Barrett MC; Clark HL; Judah DJ; Williamson G; Neal GE Carcinogenesis; 1997 Sep; 18(9):1729-38. PubMed ID: 9328168 [TBL] [Abstract][Full Text] [Related]
16. Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes. Jacobs JM; Nichols CE; Andrew AS; Marek DE; Wood SG; Sinclair PR; Wrighton SA; Kostrubsky VE; Sinclair JF Toxicol Appl Pharmacol; 1999 May; 157(1):51-9. PubMed ID: 10329507 [TBL] [Abstract][Full Text] [Related]